First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.1601 USD
Updated: Apr 30, 2024

Sonoma Pharmaceuticals Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sonoma Pharmaceuticals Inc
Gross Profit Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Gross Profit
$4.8m
CAGR 3-Years
-18%
CAGR 5-Years
-10%
CAGR 10-Years
-6%
Johnson & Johnson
NYSE:JNJ
Gross Profit
$57.4B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
1%
Bristol-Myers Squibb Co
NYSE:BMY
Gross Profit
$34.4B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Gross Profit
$40.7B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
0%
Merck & Co Inc
NYSE:MRK
Gross Profit
$44.2B
CAGR 3-Years
14%
CAGR 5-Years
9%
CAGR 10-Years
5%
Eli Lilly and Co
NYSE:LLY
Gross Profit
$27B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
4%

See Also

What is Sonoma Pharmaceuticals Inc's Gross Profit?
Gross Profit
4.8m USD

Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Gross Profit amounts to 4.8m USD.

What is Sonoma Pharmaceuticals Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
-6%

Over the last year, the Gross Profit growth was 23%. The average annual Gross Profit growth rates for Sonoma Pharmaceuticals Inc have been -18% over the past three years , -10% over the past five years , and -6% over the past ten years .